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Nonsense-mediated mRNA decay (NMD) is a surveillance pathway that degrades aberrant 
mRNAs and also regulates the expression of a wide range of physiological transcripts. 
RUVBL1 and RUVBL2 AAA-ATPases form an hetero-hexameric ring that is part of several 
macromolecular complexes such as INO80, SWR1 and R2TP. Interestingly, RUVBL1-
RUVBL2 ATPase activity is required for NMD activation by an unknown mechanism. Here, 
we show that DHX34, an RNA helicase regulating NMD initiation, directly interacts with 
RUVBL1-RUVBL2 in vitro and in cells. Cryo-EM reveals that DHX34 induces extensive 
changes in the N-termini of every RUVBL2 subunit in the complex, stabilizing a conformation 
that does not bind nucleotide and thereby down-regulates ATP hydrolysis of the complex. 
Using ATPase-deficient mutants, we find that DHX34 acts exclusively on the RUVBL2 
subunits. We propose a model, where DHX34 acts to couple RUVBL1-RUVBL2 ATPase 
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RUVBL1 and RUVBL2 are two closely related AAA-type ATPases that assemble as hetero-
hexameric structures made of alternating subunits and comprising six ADP/ATP-binding 
domains (Figure 1A). RUVBL1 and RUVBL2 contain a unique domain II (DII) that protrudes 
from one side of the hexamer and defines two distinct faces of the ring, named ATPase-face 
and DII-face hereafter (Cheung et al., 2010; Ewens et al., 2016; Gorynia et al., 2011; Lakomek 
et al., 2015; Lopez-Perrote et al., 2012). DII domains comprise an 
oligonucleotide/oligosaccharide-binding (OB) fold domain (DII external) that connects to the 
hexameric ring by a flexible region containing a ß-stalk and a helical bundle (DII internal). 
Each RUVBL1 and RUVBL2 subunit contains a nucleotide-binding pocket and the adjacent 
subunit in the hexamer provides the arginine finger motif required for hydrolysis. Several 
structures of RUVBL1-RUVBL2 complexes reveal that nucleotides are present in the complex 
even if they were not supplemented during purification (Gorynia et al., 2011; Lakomek et al., 
2015; Matias et al., 2006; Munoz-Hernandez et al., 2019). 
RUVBL1 and RUVBL2 are essential constituents of several large complexes. In various 
chromatin-remodeling complexes such as INO80 and SRCAP, these ATPases form a scaffold 
that organizes the architecture of other subunits in the complex (Aramayo et al., 2018; 
Eustermann et al., 2018; Feng et al., 2018). RUVBL1 and RUVBL2 also interact with RPAP3 
and PIH1D1 proteins to form the R2TP complex, a HSP90 co-chaperone involved in the 
assembly and maturation of some large complexes including RNA polymerase II and members 
of the Phosphatidylinositol 3-kinase-related kinase (PIKK) family such as ATR, ATM, SMG1 
and mTOR (Houry et al., 2018; Martino et al., 2018; Maurizy et al., 2018; Munoz-Hernandez 
et al., 2019; Rivera-Calzada et al., 2017). In all these complexes, the DII-face of the RUVBL1-
RUVBL2 ring is used as scaffold platform for the interaction with other proteins, which are 
recruited by the DII domains. One exception is the C-terminal domain of RPAP3 that binds at 
the ATPase-face of the ring through the interaction with RUVBL2 but not RUVBL1 (Martino 
et al., 2018; Maurizy et al., 2018; Munoz-Hernandez et al., 2019). 
ATP binding or hydrolysis by RUVBL1 and/or RUVBL2 is essential to all the reported 
activities in cells (Izumi et al., 2010; Rajendra et al., 2014; Venteicher et al., 2008), but the 
purified proteins display very weak ATPase activity in vitro (Nano et al., 2020; Gorynia et al., 
2011). Little is known about the function of RUVBL1-RUVBL2-mediated ATP hydrolysis or 
how this is regulated within the cell. Inhibition of the RUVBL1-RUVBL2 ATPase stabilizes 
interactions with clients and proteins involved in mTOR assembly in cells (Yenerall et al., 
2020). This and the low rates of ATP hydrolysis indicates that RUVBL1-RUVBL2 might not 
function as a processive ATPase but rather as a switch regulated through interacting partners. 
Recent structures suggest that the interaction of proteins with the DII domains can alter the 
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conformation of the RUVBL1-RUVBL2 hexameric ring. PIH1D1 in the R2TP complex and 
the insertion domain of Ino80 in the INO80 complex interact with the DII domains, inducing 
conformational changes in regions of the ATPase ring (Aramayo et al., 2018; Munoz-
Hernandez et al., 2019). In the R2TP complex, the interaction of PIH1D1 also induces changes 
in a region at the N-terminus of one RUVBL2 subunit that contains two histidine residues 
(His25 and His27) that contribute to the interaction with the nucleotide. However, it has not been 
demonstrated whether these changes could regulate the ATPase activity of RUVBL1-
RUVBL2. 
 In addition to their role as components of some macromolecular complexes, RUVBL1 and 
RUVBL2 regulate several cellular processes, including the Fanconia Anemia (FA) pathway, 
the assembly of the telomerase holoenzyme, and nonsense-mediated mRNA decay (NMD), a 
mechanism that removes aberrant transcripts. In FA, RUVBL1 and RUVBL2 associate with 
some components of the pathway, and their depletion reduces the amount of the FA core 
complex (Rajendra et al., 2014). Interestingly, monoubiquitination of FANCD2 and FANCI, a 
measure of the activation of the FA pathway, can be rescued by siRNA-resistant versions of 
RUVBL1 but not by an ATPase-dead mutant. The assembly of the human telomerase 
holoenzyme also requires RUVBL1 and RUVBL2 and the levels of assembled telomerase in 
RUVBL1-depleted cells can be rescued by the expression of the wild-type protein but not by 
an ATPase-deficient mutant (Venteicher et al., 2008). An ATPase active RUVBL1-RUVBL2 
complex is also required for phosphorylation of UPF1 by the SMG1 kinase, one of the key 
steps to initiate NMD (Izumi et al., 2010). In this work, we focus on the study of RUVBL1 and 
RUVBL2 ATPases in the context of the NMD pathway.   
 NMD controls the quality of mRNAs by removing aberrant transcripts containing premature 
termination codons (PTCs). These are generated as errors during transcription or splicing, but 
they also appear through germline mutations in a number of genetic disorders (Hug et al., 2016; 
Kurosaki et al., 2019). NMD also plays an important role in fine-tuning gene expression by 
regulating the abundance of a significant fraction of physiological transcripts (Nasif et al., 
2018), affecting functions such as stem cell differentiation (Lou et al., 2016). NMD is initiated 
by the assembly of transient multi-subunit complexes containing the up-frameshift (UPF) core 
NMD factors, UPF1, UPF2 and UPF3b, bound to the target mRNA (Hug et al., 2016; Kurosaki 
et al., 2019). First the RNA helicase UPF1 and its specific kinase SMG1 bind to eukaryotic 
release factors eRF1 and eRF3 at ribosomes stalled at a PTC, forming the so-called surveillance 
(SURF) complex, where SMG1 is inhibited by the interaction of SMG8 and SMG9, two factors 
that block the access to the kinase domain (Gat et al., 2019; Melero et al., 2014; Zhu et al., 
2019). Remodeling of the SURF complex by the interaction with NMD core factors UPF2 and 
UPF3b bound to the Exon Junction Complex (EJC) leads to the phosphorylation of UPF1 by 
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SMG1, which results in the recruitment of factors that promote mRNA degradation. A fully 
functional NMD response requires the contribution of several other proteins beyond the core 
NMD machinery, including DHX34 (DEAH box protein 34), a DEAH box family RNA 
helicase that is required to initiate NMD (Hug and Caceres, 2014; Longman et al., 2007). 
DHX34 is made of a structural core containing two canonical recombinase A (RecA)-like 
domains, a winged-helix domain (WH), a helical bundle (the Ratchet domain), and an OB-fold 
domain, followed by a short C-terminal domain (CTD) (Hug and Caceres, 2014; Melero et al., 
2016). DHX34 promotes UPF1 phosphorylation and although the mechanism is unknown, 
current evidence suggests this occurring in complex with the SMG1 kinase and its substrate 
UPF1. A region around the RecA domains in DHX34 binds UPF1 directly whereas the CTD 
interacts with SMG1 (Hug and Caceres, 2014; Melero et al., 2016). DHX34 variants lacking 
the CTD domain fail to promote the degradation of a PTC-containing NMD reporter (Melero 
et al., 2016). Only recently, germline pathogenic variants of DHX34 were found in four 
families as specific to familiar forms of acute myeloid leukemia (AML) and myelodysplastic 
syndrome (MDS) (Rio-Machin et al., 2020). Interestingly, the four variants reduced the 
recruitment of UPF2 and UPF3b to UPF1, resulting in reduced UPF1 phosphorylation, 
suggesting a link between DHX34, the NMD pathway and the etiology of some inherited forms 
of these myeloid malignances. 
RUVBL1 and RUVBL2 are also potential new non-canonical NMD regulators. Knockdown 
of RUVBL1 or RUVBL2 reduces SMG1-mediated UPF1 phosphorylation and affects the 
degradation of a PTC-containing  b-globin reporter. These defects could only be recovered 
with wild-type and not ATPase-dead mutant versions of RUVBL1 indicating that the ATPase 
activity of the RUVBL1-RUVBL2 complex is required to initiate the NMD response (Izumi et 
al., 2010). How RUVBL1 and RUVBL2 participate in NMD and how their ATPase activity is 
regulated in this pathway remains enigmatic. 
 Here we demonstrate that RUVBL1-RUVBL2 hetero-hexamers can bind directly to DHX34 
in vitro and in cells in culture. Cryo-electron microscopy (cryo-EM) reveals that DHX34 
induces global conformational changes in the RUVBL1-RUVBL2 complex with the RUVBL2 
subunit being mostly affected. DHX34 destabilizes the N-termini of all RUVBL2 subunits and 
in consequence ATP hydrolysis activity by RUVBL2 is reduced. This demonstrates that 
interacting partners can profoundly affect the structure and activity of RUVBL1-RUVBL2 
hetero-hexameric complexes. Our results suggest that DHX34 could couple the regulation of 
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RUVBL1-RUVBL2 and DHX34 form a complex in vitro and in cells 
To uncover the function of RUVBL1 and RUVBL2 in NMD, we sought to address whether 
these AAA-ATPases can interact directly with some of the core protein factors involved in the 
initiation of NMD. Pull-down experiments from cell extracts cannot easily differentiate direct 
interactions from those associations that are mediated by connecting partners. Thus, we first 
tested which NMD factors could bind directly to RUVBL1-RUVBL2 using purified proteins 
and in vitro interaction assays, and subsequently verified them in cell lysates. 
For this, RUVBL1 and RUVBL2 were co-expressed and purified as heteromeric complexes 
containing His-RUVBL1 and RUVBL2 in equimolar amounts, and forming oligomeric 
complexes where two hexameric rings interact though the DII domains, as revealed by cryo-
EM (Figure 1 — figure supplement 1A), and in agreement with what we described before 
(Lopez-Perrote et al., 2012; Martino et al., 2018). We first tested the interaction between 
RUVBL1-RUVBL2 complexes and UPF1115-914 (a truncated version lacking the flexible N- 
and C-terminal ends of UPF1), UPF2, UPF3b, EJC and DHX34 by pull-down experiments 
using the His-tag in RUVBL1 (Figure 1B, Figure 1 — figure supplement 1B-D). Of all these, 
only DHX34 interacted directly with RUVBL1-RUVBL2 forming a stable complex that has 
not been previously described. We then verified the in vitro results using immunoprecipitation 
experiments from cells. When DHX34 was pulled down from cells, both RUVBL1 and 
RUVBL2 were detected by Western blot (Figure 1C-D). The interaction between DHX34, 
RUVBL1 and RUVBL2 in cell lysates was further confirmed in immunoprecipitation 
experiments using FLAG-RUVBL1 (Figure 1E). FLAG-RUVBL1 eluted also endogenous 
RUVBL1 and RUVBL2, in agreement with the oligomeric nature of the complexes formed by 
these ATPases. Together, these results reveal a direct interaction between RUVBL1 and 
RUVBL2 and DHX34. 
We also analyzed the interaction with SMG1, the kinase that phosphorylates UPF1, since 
this is the key event triggering NMD and RUVBL1-RUVBL2 has been found in complexes 
containing SMG1 in cell extracts (Izumi et al., 2010). SMG1 was purified by affinity 
chromatography in complex with SMG8 and SMG9 and incubated with His-RUVBL1-
RUVBL2. A pull-down experiment using the His-tag in RUVBL1 revealed that SMG1 forms 
a direct complex with RUVBL1-RUVBL2 and similar results were obtained in pull-down 
experiments using a FLAG-tag in SMG1 as bait. Curiously, in both types of experiments, 
SMG1 and RUVBL1-RUVBL2 interact but SMG8 and SMG9 were undetected in the elution, 
suggesting that the formation of a complex between RUVBL1-RUVBL2 and SMG1 exclude 
SMG8 and SMG9 (Figure 1 — figure supplement 1E-F). 
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Together, these results indicate that RUVBL1-RUVBL2 can interact directly with the NMD 
factors SMG1 and DHX34. In this work we focused on the characterization of how DHX34 
binds to RUVBL1-RUVBL2 and the consequences of this interaction. 
 
Cryo-EM of the RUVBL1-RUVBL2-DHX34 complex 
To gain deeper insight into the consequences of the interaction of DHX34 with RUVBL1 and 
RUVBL2, we purified the RUVBL1-RUVBL2-DHX34 complex for structural 
characterization. The purification was optimized so that yields and homogeneity of the 
complex were suitable for structural studies (Figure 2A). For this, we coupled the purification 
of DHX34 from HEK293 cells with its binding to RUVBL1-RUVBL2. FLAG-DHX34 from 
cell extracts was bound to an immunoaffinity anti-FLAG resin and the beads were washed and 
incubated with purified RUVBL1-RUVBL2 prior to elution. Next, we used cryo-EM to 
determine the structure of the RUVBL1-RUVBL2-DHX34 complex. Freshly purified 
RUVBL1-RUVBL2-DHX34 was applied to holey-carbon grids, vitrified and cryo-EM images 
were collected.  
2D averages of RUVBL1-RUVBL2-DHX34 revealed hexameric RUVBL1-RUVBL2 
complexes with putative density for DHX34 located at the DII-face of the ring. The interaction 
of DHX34 disrupts the RUVBL1-RUVBL2 dodecameric double-ring complexes, an effect 
observed before in the assembly of R2TP (Martino et al., 2018; Munoz-Hernandez et al., 2019) 
(Figure 2B). An extensive 2D and 3D classification strategy of the images revealed that 
DHX34 attaches to the DII-face of the RUVBL1-RUVBL2 ring flexibly and we selected the 
most homogenous sub-group of particles for refinement (Figure 2 — figure supplement 1, table 
1). The structure of RUVBL1-RUVBL2-DHX34 was determined at an average resolution of 
5.0 Å (Figure 2 — figure supplement 2A), with local resolutions up to 4.1 Å for the core 
RUVBL1-RUVBL2 whereas the resolution of DHX34 in the complex was around 8-10 Å 
(Figure 2 — figure supplement 2B — Video 1). The disparity in resolution between DHX34 
and RUVBL1-RUVBL2 in the complex was a strong indication of the flexible attachment of 
DHX34 to the ATPases. Thus, the cryo-EM density for DHX34 could represent an average of 
several conformations if the hexameric RUVBL1-RUVBL2 directs alignment during image 
processing. Local resolution estimation for the OB folds in the DII domains of RUVBL1-
RUVBL2 showed a similar resolution distribution (8-10 Å) due to their intrinsic flexibility 
(Figure 2 — figure supplement 2B) (Martino et al., 2018). 
DHX34 binds to the internal regions of the DII domains in the hetero-hexameric RUVBL1-
RUVBL2 ring. The DII external domains (OB-folds) are mostly free and potentially accessible 
for interaction with other partners (Figure 2C). DHX34 contacts several RUVBL1 and 
  Lopez-Perrote et al. 2020  
 
 8 
RUVBL2 subunits of the complex, thus inducing global conformational changes in the 
structure of the ATPases (see below). 
 
DHX34 induces conformational changes in the N-termini of RUVBL2 
We first analyzed the structure of the RUVBL1-RUVBL2 ring using a mask that removed the 
influence of DHX34 and the protruding OB-fold domains during image processing (Figure 2 
— figure supplement 1). This way the average resolution of RUVBL1-RUVBL2 improved to 
4.2 Å (Figure 3A, Figure 3 — figure supplement 1A, B, table 1) detecting the presence or 
absence of nucleotide in the nucleotide-binding pockets of both subunits (Figure 3 — figure 
supplement 1C, D). The resolution was sufficient to model the structure of the RUVBL1-
RUVBL2 ring after its interaction with DHX34 with the help of the crystal structure of 
RUVBL1-RUVBL2 (PDB 2XSZ) (Figure 3 — figure supplement 2A-C, table 2-3). 
The most striking feature in the cryo-EM map is that the N-terminal regions that contribute 
to nucleotide binding (Munoz-Hernandez et al., 2019; Silva et al., 2018) are visualized in 
RUVBL1 but not in any of the three RUVBL2 subunits (Figure 3A, B). We performed several 
experiments to fully verify that every RUVBL2 in the complex lacked density for the N-
terminal region. We first searched for heterogeneity in RUVBL1-RUVBL2 by classifying the 
images of the ring in several 3D subgroups using a mask and we did not find sub-populations 
of particles where the N-terminal region of RUVBL2 was visible (Figure 3 — figure 
supplement 3). Next, we classified every position of RUVBL1-RUVBL2 dimers in 6 
subclasses to search for heterogeneities within each position (Figure 3 — figure supplement 
4). More than 70 % of particles in every position corresponded to particles clearly missing 
density of RUVBL2 N-terminus. Density for the N-terminus was not well defined for a small 
fraction of particles, but these corresponded to low-resolution structures due to the small 
number of images in these sub-groups. Finally, we applied a symmetry expansion strategy as 
described before (Martino et al., 2018). For this, we rotated each particle around the 3-fold 
symmetry axis three times (0º, 120º and 240º) to place all RUVBL1-RUVBL2 dimers in the 
same position, thus triplicating the data set. Next, by placing a mask around one position now 
containing all existing RUVBL1-RUVBL2 dimers, we subjected the symmetry-expanded data 
to classification, searching for heterogeneity in all the available RUVBL1-RUVLB2 dimers 
regardless of its position in the ring (Figure 3 — figure supplement 5). This analysis further 
confirmed that all dimers lack the RUVBL2 N-terminal regions. Based on these observations 
we conclude that DHX34 induce changes that affect the conformation of RUVBL2 N-terminal 
regions in all three subunits of the complex. 
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DHX34 induces the loss of nucleotide in every RUVBL2 subunit 
The conformational changes in the N-terminus of RUVBL2 were coupled to the loss of 
nucleotide (Figure 3C). We and others have observed that RUVBL1-RUVBL2 co-purifies with 
nucleotides bound to all six subunits (Gorynia et al., 2011; Lakomek et al., 2015; Matias et al., 
2006; Munoz-Hernandez et al., 2019), but whereas nucleotide remains bound to RUVBL1 in 
the RUVBL1-RUVBL2-DHX34 complex (Figure 3D), this is lost in all three RUVBL2 
subunits (Figure 3E). The absence of density for nucleotide in RUVBL2 could not be attributed 
to a lack of sufficient resolution because nucleotides are clearly present in all RUVBL1 
subunits in the same complex at similar resolution (Figure 3 — figure supplement 1C, D). 
DHX34 induces conformational changes in other regions of RUVBL1 and RUVBL2 besides 
the N-termini of RUVBL2 (Figure 3 — figure supplement 2B — Video 2). These changes 
affect mostly to the internal regions of the DII domains and regions in the AAA-ring. These 
changes do not affect key residues of the RUVBL1 nucleotide-binding pocket, which explains 
why ADP remains bound to RUVBL1 after the interaction with DHX34 (Figure 3D). The 
structure of the nucleotide binding pocket in RUVBL2 is not altered significantly with respect 
to the crystal structure of RUVBL2 bound to nucleotide (Figure 3E). This suggests that it is the 
displacement of the N-termini of RUVBL2 that is mostly responsible for the loss of nucleotide.  
Together, our results reveal that DHX34 affects nucleotide binding of every RUVBL2 subunit 
in the complex by stabilizing a conformation that displaces the N-termini of RUVBL2. 
 
DHX34 makes multiple contacts through different domains with RUVBL1-RUVBL2 
Next, we focused on the analysis of the structure of DHX34, whose resolution was lower than 
that of the RUVBL1-RUVBL2 hexameric ring. In an attempt to improve the resolution of 
DHX34 we extracted the density corresponding to the protein in each particle by applying 
density subtraction methods. These images were processed and classified without the influence 
of RUVBL1-RUVBL2 (Figure 4 — figure supplement 1A, B). Despite our efforts, we were 
unable to improve the structure of DHX34. We suspect this could be a consequence of the 
limited number of images since small proteins need large datasets that allow classification and 
identification of the best particles in a homogenous conformation. This also indicates that the 
density of DHX34 of the cryo-EM map resolved in the context of the full RUVBL1-RUVBL2-
DHX34 complex could be affected by the alignment of the AAA ring. 
In isolation and at low resolution using negative-stain electron microscopy methods, 
DHX34 appears as a globular and compact protein comprising all of the conserved core 
domains, attached to a protruding extension corresponding to the C-terminal domain (CTD) 
(Melero et al., 2016) (Figure 4 — figure supplement 1C). The CTD domains appears thicker 
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in the volume of DHX34 than in the electron microscopy images used to obtain the low-
resolution structure due to its flexibility and the use of staining agents (Melero et al., 2016). 
We compared the cryo-EM volume of DHX34 extracted from the RUVBL1-RUVBL2-DHX34 
complex with the low-resolution map of isolated DHX34. This comparison revealed that the 
dimensions of the DHX34 density that we observe attached to one ring of RUVBL1-RUVBL2 
can only agree with one copy of DHX34, and that possibly, it is the DHX34 core domains and 
not the CTD that interact with RUVBL1-RUVBL2. Accordingly, purified DHX34 can still 
bind RUVBL1-RUVBL2 when its flexible C-terminal domain has been deleted (Figure 4 — 
figure supplement 1D). In addition, we estimated that the approximate mass of the volume 
occupied by DHX34 in the complex with RUVBL1-RUVBL2 is around 120 kDa by using the 
volume programme in EMAN (Ludtke et al., 1999) (https://blake.bcm.edu/emanwiki/Volume). 
This tool estimates the mass enclosed by an isosurface using an average density for proteins of 
1.35 g/ml (0.81 Da/A3). Monomeric DHX34 and the DHX34 core domains alone have a 
molecular mass of 132 kDa and 111 kDa respectively. Together, these analyses strongly 
suggest that one copy DHX34 interacts with one RUVBL1-RUVBL2 hexamer forming a 
complex with 3:3:1 stoichiometry. 
Next, we tested whether any individual domain of DHX34 could have a significant role in 
mediating the interactions with RUVBL1-RUVBL2 in cultured cells. For this, we analyzed 
several DHX34 mutants (Figure 4A). We first tested a series of systematic domain deletion 
mutants and found that all single domain deletions retained binding to RUVBL1 and RUVBL2 
to a measurable degree (Figure 4B). In order to test the importance of several DHX34 domains 
for RUVBL1 and RUVBL2 binding we next analyzed larger truncated versions of DHX34 
(Figure 4C). As shown by the quantification in Figure 4D, no domain is sufficient and 
necessary on its own to mediate the interaction with RUVBL1-RUVBL2. Heavily N- and C- 
terminal truncated versions of DHX34 showed a pronounced reduction in binding to RUVBL1-
RUVBL2 but they could still bind to the ATPases (Figure 4D). Overall this analysis indicated 
that several interactions through different domains are made between DHX34 and RUVBL1-
RUVBL2, which agrees with the structure of the complex that shows multiple regions of 
contact between DHX34 and the ATPases. 
 
DHX34 down-regulates RUVBL2 ATPase activity 
We analyzed if the conformational changes induced by DHX34 correlate with changes in the 
ATPase activity of the His-RUVBL1-RUVBL2 complex (Figure 5). For these experiments we 
expressed and purified the ATP-hydrolysis deficient His-RUVBL1E303Q-RUVBL2E300Q mutant 
(Gorynia et al., 2011; Lakomek et al., 2015; Matias et al., 2006). We investigated whether these 
mutations affect the oligomerization of the complex using electron microscopy (Figure 5 — 
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figure supplement 1A). We found that His-RUVBL1E303Q-RUVBL2E300Q forms similar 
oligomers to the wild-type complex and, in addition, it behaves similarly to His-RUVBL1-
RUVBL2 when their intrinsic fluorescence was measured using a thermal denaturation assay 
(Figure 5 — figure supplement 1B). In addition, we purified His-RUVBL1E303Q-RUVBL2 and 
His-RUVBL1-RUVBL2E300Q containing the mutation in either RUVBL1 or RUVBL2. We also 
purified ATP-hydrolysis-dead mutant (DHX34D279A) to remove the effects of ATP hydrolysis 
by DHX34 in our experiments (Hug and Caceres, 2014). DHX34D279A showed an ATP 
consumption of 24.2% compared with wild-type (Figure 5 — figure supplement 1C-E). We 
also monitored DHX34 stability when incubated at 37ºC, measured as changes in the intrinsic 
fluorescence during a thermal ramp. We found that DHX34 is not affected by 20 min 
incubation time but it is by 40 min when compared to freshly purified DHX34 (Figure 5 — 
figure supplement 1F). This suggested that the protein might not be stable over long incubation 
times. Thus, ATPase measurements were restricted to 20 min using fresh preparations for 
which linearity of ATPase rates were maintained.  
The ATPase activity of His-RUVBL1-RUVBL2 was determined using a 
spectrophotometric pyruvate kinase-lactate dehydrogenase-coupled assay that regenerates 
ATP so that the amount remains constant. The weak ATPase activity of His-RUVBL1-
RUVBL2 that we measured at 37ºC (4.9±0.8 min-1 of ATP turnover) is similar to what had 
been determined previously by others (Gorynia et al., 2011; Lakomek et al., 2015; Matias et 
al., 2006) (Figure 5 — figure supplement 2A), and this value was set as 100 % activity for 
comparison with subsequent measurements (Figure 5A). We verified that the activity measured 
corresponded to His-RUVBL1-RUVBL2 using His-RUVBL1E303Q-RUVBL2E300Q (Figure 5A, 
Figure 5 — figure supplement 2A). His-RUVBL1-RUVBL2E300Q and His-RUVBL1E303Q-
RUVBL2 complexes that are mutants in only one of the two subunits showed a significant 
reduction of their ATPase activity as expected if not all the subunits in each oligomer are active 
(43% and 20% ATPase activity for His-RUVBL1-RUVBL2E300Q and His-RUVBL1E303Q-
RUVBL2, respectively, compared to wild-type His-RUVBL1-RUVBL2) (Figure 5A, Figure 5 
— figure supplement 2A). 
 We then analyzed the consequences of adding DHX34 (2:1 DHX34:His-RUVBL1-
RUVBL2 molar ratio, considering a His-RUVBL1-RUVBL2 hexamer and monomeric 
DHX34). Interestingly, the ATPase activity was reduced around 50% (2.5±0.9 min-1) (Figure 
5B, Figure 5 — figure supplement 2B). Most interestingly, adding DHX34 caused no effects 
in His-RUVBL1-RUVBL2E300Q complexes containing ATPase-dead RUVBL2 subunits (His-
RUVBL1-RUVBL2E300Q showed rates of 2.1±0.5 and 2.0±0.5 min-1 in the absence and 
presence of DHX34D279A, respectively) (Figure 5C, Figure 5 — figure supplement 2C). In 
contrast, ATP hydrolysis by the His-RUVBL1E303Q-RUVBL2 mutant was affected by DHX34 
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as in the wild-type (His-RUVBL1E303Q-RUVBL2 showed rates of 1.0±0.3 and 0.4±0.1 min-1 in 
the absence and presence of DHX34D279A, respectively) (Figure 5C, Figure 5 — figure 
supplement 2D). These results are fully in agreement with a model where DHX34 actions on 
the RUVBL1-RUVBL2 complex are mediated mostly by changes in the RUVBL2 subunits. 
Finally, we verified that our results were independent of the presence or absence of the His-
tag in RUVBL1 used to purify RUVBL1-RUVBL2. Removal of the tag had a small effect on 
the rate of ATP hydrolysis of the RUVBL1-RUVBL2 complex (3.6±0.7 min-) (Figure 5 — 
figure supplement 3A, B) but addition of DHX34 caused a similar reduction of ATP hydrolysis 
(1.0±0.5 min-1), indicating that the presence of the tag does not interfere with the action of 
DHX34 (Figure 5 — figure supplement 3C, D). As in the case of complexes containing His-
RUVBL1, DHX34 caused a reduction in the ATPase activity of untagged RUVBL1-RUVBL2 
complexes when RUVBL1 was mutated but not when RUVBL2 was mutated (Untagged 
RUVBL1-RUVBL2E300Q mutant consumed 2.0±0.5 and 1.8±0.1 min-1 in the absence and 
presence of DHX34D279A, respectively; and untagged RUVBL1E303Q-RUVBL2 mutant showed 
rates of 1.1±0.5 and 0.5±0.2 min-1 in the absence and presence of DHX34D279A, respectively) 
(Figure 5 — figure supplement 3E-G). 
Together, these results indicate that there is a correlation between the conformational 
changes induced by DHX34 and the ATP hydrolysis activity of the complex. Thus, DHX34 




Several lines of evidence show that the ATPase activity of RUVBL1 and RUVBL2 regulates 
several cellular processes. In particular, RUVBL1 and RUVBL2 ATPase activity is needed for 
a fully functional NMD response and for normal levels of SMG1-mediated UPF1 
phosphorylation in vivo (Izumi et al., 2010); however, how these ATPases regulate NMD was 
completely unknown. Here, we provide evidence that RUVBL1 and RUVBL2 directly interact 
with a subset of factors involved in the initiation of the NMD response and these interactions 
can affect greatly the conformation of RUVBL1-RUVBL2 oligomers and their ATPase 
activity. RUVBL1-RUVBL2 hetero-hexameric complexes interact directly with SMG1 and 
also with DHX34, two factors involved in regulating NMD initiation. SMG1 is the kinase that 
phosphorylates UPF1, one of the key events that dictates that an mRNA is targeted for 
degradation (Kurosaki et al., 2019). In this work we focused on the study of the complex 
between RUVBL1-RUVBL2 and DHX34, a novel interaction that we find in vitro and in cells 
in culture. DHX34 is an RNA helicase that binds SMG1 and UPF1 and promotes the interaction 
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of UPF1 with UPF2 and UPF3b, UPF1 phosphorylation and the initiation of NMD (Hug and 
Caceres, 2014; Melero et al., 2016). Interestingly, variants of DHX34 unable to facilitate UPF1 
phosphorylation have been found as pathogenic versions specific to inherited forms of acute 
myeloid leukemia (AML) and myelodysplastic syndrome (MDS) (Rio-Machin et al., 2020).  
 The regulation of RUVBL1-RUVBL2 ATPase activity is poorly understood. The N-termini 
of RUVBL1 and RUVBL2 contain two histidine residues, His25 and His27 in RUVBL2, that 
bind the nucleotide and contribute to maintain it within its binding pocket (Munoz-Hernandez 
et al., 2019; Silva et al., 2018). Here, cryo-EM reveals that the NMD factor DHX34 directly 
affects the conformation of RUVBL2 N-termini and decreases ATP hydrolysis. DHX34 
distorts the N-terminal regions in all three RUVBL2 subunits that are not visible in the map, 
an indication that they are flexible and not attached to the hexameric ring after DHX34 binding. 
Thus, these changes provide an exit route for nucleotides, which are lost in all the RUVBL2 
subunits (Figure 5D). We find that DHX34 down-regulates the ATPase activity of the 
RUVBL1-RUVBL2 complex in vitro. Importantly, these effects are mediated exclusively by 
changes in RUVBL2 and not in RUVBL1, as shown by RUVBL2 ATPase-dead mutants not 
being sensible to DHX34. Together, these results show that DHX34 stabilizes a conformation 
of RUVBL2 unable to hydrolyze ATP. 
Despite conformational changes occurring in RUVBL1 and RUVBL2, major changes and 
loss of nucleotide is only observed in the RUVBL2 subunits. It remains unclear how this 
translates to the function of the hexameric ring, but this argues in favor of a model where 
RUVBL1 and RUVBL2 perform different functions in the complex. Some evidence supports 
this model. Several reports indicate that RUVBL1 and RUVBL2 do not always share the same 
function in vivo (Mao and Houry, 2017). The ATPase activity of RUVBL2 is several fold 
higher than RUVBL1 at least when expressed separately (Nano et al, 2020), suggesting they 
do not function in the same way. Along the same lines, RUVBL2 shows several specialized 
functions in the context of the R2TP complex. RUVBL2 binds RPAP3 and PIH1D1, two 
subunits of the R2TP complex, functions not shared by RUVBL1. Interestingly, cordycepin, a 
derivative of the nucleoside adenosine affects the circadian clock in mammals by targeting 
RUVBL2 (Ju et al., 2020). A crystal structure of RUVBL1-RUVBL2 bound to cordycepin 
(PDB 6K0R) shows that the compound interacted with all RUVBL2 subunits but not with 
RUVBL1 and the N-termini of RUVBL2 were visible and folded into the protein. Therefore, 
it seems that RUVBL1 and RUVBL2 subunits could have specialized functions within the 
complex, maybe also in the context of NMD.  
 The role of RUVBL1-RUVBL2 ATPase activity in cells is not understood beyond the fact 
that ATP binding and/or hydrolysis is essential in vivo for all the cellular pathways in which 
this has been analyzed. Thus, what the regulation of their ATPase activity could mean for NMD 
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in cells is completely unknown. Purified RUVBL1-RUVBL2 complexes display low but 
measurable ATPase activity, which suggests that the complex might not work as a molecular 
motor but rather as a switch regulated by the interaction of partners. Recent experiments 
showed that RUVBL1 and RUVBL2 could pull-down partners of the R2TP chaperone pathway 
more efficiently when an inhibitor of their ATPase activity is used (Yenerall et al., 2020). This 
was interpreted as an indication that RUVBL1-RUVBL2 may form more stable complexes in 
the absence of ATP hydrolysis and that hydrolysis could serve to disengage RUVBL1-
RUVBL2 from its partners. The initiation of the NMD response requires the assembly of 
several transient macromolecular complexes involving core and auxiliary NMD factors (Hug 
et al., 2016; Kurosaki et al., 2019). Only when the right set of interactions has taken place, 
SMG1 kinase phosphorylates UPF1, which triggers a transition from an initial surveillance 
complex (SURF) to a decay-inducing complex (DECID) and mRNA decay. DHX34 interacts 
with both SMG1 and its substrate UPF1 and somehow promotes interactions with other NMD 
factors that activate UPF1 phosphorylation (Hug and Caceres, 2014; Melero et al., 2016). We 
can speculate that RUVBL1-RUVBL2 could contribute to these events by providing a platform 
that facilitates some of this complex set of interactions, coupling their ATPase activity to the 
formation of some of the NMD complexes. The inhibition of RUVBL1-RUVBL2 ATP 
hydrolysis by DHX34 could maybe serve to stabilize this interaction while waiting for other 
NMD factors to bind DHX34 and RUVBL1-RUVBL2.  
 Together, our results reveal that DHX34, an NMD factor involved in NMD initiation, 
interacts directly with RUVBL1-RUVBL2 hetero-hexameric rings, profoundly modifying their 
structure and affecting their ATPase activity. This could help to couple RUVBL1-RUVBL2 
ATPase activity to the assembly of the complexes required to initiate the NMD response. 
 
 
Materials and Methods 
Transfections, Immunoprecipitations and Western Blotting 
For interactions studies in cell extracts HEK293T cells were transfected with pcG T7-DHX34 
(WT and deletion mutants), pcDNA3-3xFLAG-UPF1 as described previously (Hug and 
Caceres, 2014; Melero et al., 2016), pCDNA-3xHA-Reptin or pCDNA-3xFLAG-Pontin 
(Izumi et al., 2010; Rajendra et al., 2014; Venteicher et al., 2008) (Addgene plasmids), 
pcIneoFLAG-UPF2 (generous gift from Andreas Kulozik, Heidelberg) using Lipofectamine 
2000 (Life Technologies) according to the manuals instructions. Cells were harvested and lysed 
48 hours after transfection. Immunoprecipitation were performed, as previously described 
(Hug and Caceres, 2014). Briefly, cells were lysed in IP buffer (10 mM Tris-HCl pH 8, 150 mM 
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NaCl, 1 mM EGTA, 1% (v/v) NP-40, 0.2% (v/v) Na-Deoxycholate, Complete Protease 
Inhibitor (Roche), 1 mM dithiothreitol (DTT), 20 μg/ ml RNase A (ThermoScientific). After 
Immunoprecipitations using T7 agarose (69026, MERCK Millipore), Anti-FLAG M2 Affinity 
Gel (A2220, Sigma-Aldrich) or antibodies against UPF1 (A300-038A, Bethyl) or UPF2 (sc-
20227, Santa Cruz) coupled to protein G, immunoprecipitated proteins were separated by SDS-
PAGE and detected by Western Blotting. RUVBL1 and RUVBL2 were detected with the 
following commercial antibodies: anti-Pontin (06-1299, Sigma Aldrich), anti-Reptin 
(SAB4200115, Sigma-Aldrich). FLAG and T7 affinity tags were detected with anti-FLAG 
(F3165, M2 clone, Sigma-Aldrich) and anti-T7 antibody (69522, Sigma Aldrich) respectively. 
The anti-DHX34 antibody has been previously described (Hug et al., 2014). Signals were 




HEK293T cells were grown in high glucose Dulbecco's modified Eagle's medium (Life 
Technologies) supplemented with 10% (v/v) fetal calf serum (Life Technologies) and 
penicillin-streptomycin (Life Technologies) and incubated at 37°C in the presence of 5% CO2. 
 
Cloning  
For mapping experiments, a C-terminal His-tagged version of human RUVBL2 was produced. 
The cDNA of RUVBL2 (NM_006666) was PCR amplified from previously described 
pCDFDuet-1-RUVBL2 plasmid (Lopez-Perrote et al., 2012) and inserted into pET21b vector 
(Novagen) using the IVA cloning system (Garcia-Nafria et al., 2016), including 10 histidine 
residues at the C-terminus of the protein. RUVBL1 and RUVBL2 ATPase-dead mutants 
RUVBL1E303Q and RUVBL2E300Q unable to hydrolyze ATP were generated by site-directed 
mutagenesis of the original plasmids previously described (pETEV15b-RUVBL1 and 
pCDFDuet-1-RUVBL2) using standard protocols (Lopez-Perrote et al., 2012). 
Oligonucleotides used for cloning are shown in Table 4. 
 
Expression and purification of recombinant proteins in bacteria 
RUVBL2 including C-terminal His-tag (RUVBL2-His) was expressed in BL21 (DE3) E. coli 
cells (NZYTech) grown in LB medium. Expression of the protein was induced by addition of 
IPTG (Isopropyl β-D-1-thiogalactopyranoside) at a final concentration of 0.1 mM at 28ºC for 
4 hours when cells reached an optical density (OD) of 0.5. Cells were collected by 
  Lopez-Perrote et al. 2020  
 
 16 
centrifugation at 8000 rpm during 10 min at 4ºC, and the pellet was resuspended in lysis buffer 
(50 mM Tris-HCl pH 7.4, 300 mM NaCl, 10% (v/v) glycerol, 0.1% (v/v) NP-40) supplemented 
with a cocktail of proteases inhibitors (cOmplete™ EDTA-free, Roche) and lysozyme (final 
concentration 0.1 mg/ml) (Sigma-Aldrich). Cells were lysed by sonication and clarified by 
centrifugation at 35000 rpm for 1 h at 4ºC. Supernant containing soluble proteins was filtered 
using a 0.45 µm device and applied to a HisTrap HP affinity column (GE Healthcare) 
equilibrated in buffer A (40 mM Tris-HCl pH 7.4, 200 mM NaCl, 10% (v/v) glycerol, 40 mM 
imidazole). Elution was performed using a gradient of increasing concentrations of imidazole 
with buffer B (40 mM Tris-HCl pH 7.4, 200 mM NaCl, 10% (v/v) glycerol, 500 mM 
imidazole). Fractions containing purified RUVBL2-His were pooled and dialyzed in buffer QA 
(40 mM Tris-HCl pH 7.4, 150 mM NaCl, 5% (v/v) glycerol) at 4ºC during 16 h. As a second 
purification step, dialyzed sample was applied on a HiTrap HP Q column (GE Healthcare) 
equilibrated in buffer QA and eluted in a gradient with increasing concentrations of NaCl using 
buffer QB (40 mM Tris-HCl pH 7.4, 1 M NaCl, 5% (v/v) glycerol). Fractions containing 
purified RUVBL2-His were dialyzed in buffer 40 mM Tris-HCl pH 7.4, 300 mM NaCl, 5% 
(v/v) glycerol at 4ºC for 16 h, freeze in liquid nitrogen, and storage at -80ºC.  
 Expression and purification of His-RUVBL1 and His-RUVBL1-RUVBL2 complex were 
performed as previously described (Lopez-Perrote et al., 2012). ATPase-dead mutants His-
RUVBL1E303Q-RUVBL2, His-RUVBL1-RUVBL2E300Q, and His-RUVBL1E303Q-
RUVBL2E300Q were expressed and purified using the same protocol as for wild-type RUVBL1-
RUVBL2. Untagged RUVBL1-RUVBL2 complexes including ATPase-dead mutants were 
obtained by TEV protease digestion as previously described (Lopez-Perrote et al., 2012). 
Untagged UPF1115-914 (UPF1 lacking residues 115-914 to increase protein stability), UPF2, 
UPF3b and EJC (composed of eIF4AIII, Btz, MAGO and Y14 proteins) were produced as 
previously described (Melero et al., 2012). Chromatographic experiments were analyzed by 4-
15% SDS-PAGE (MINI-PROTEAN TGX stain-free, Bio-Rad) and Quick Coomassie 
(Generon) staining. 
 
Expression and purification of recombinant proteins in mammalian cells 
SMG1-SMG8-SMG9 complex was produced in HEK293T cells following previously 
published protocols, including tandem FLAG-SBP-HA tags at the N-terminus of SMG1, and 
Strep-HA tags at the N-terminus of SMG8 and SMG9. The SBP-tag at the N-terminus of SMG1 
was used for purification by affinity chromatography as described before (Melero et al., 2014). 
 3xFLAG-DHX34, either wild-type, ATPase mutant D279A, or the deletion mutant 
DHX34_DCTD (lacking residues 956-1143) were expressed in suspension HEK293GnTi- cells 
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by transient transfection of the pCDNA vectors containing the different constructs of the 
DHX34 gene. Cells were grown in Freestyle 293 Expression Medium (Gibco) supplemented 
with 1% fetal bovine serum (FBS) in 5% CO2 and 95% humidity with agitation. 24 h prior 
transfection, 500 ml of cells were seed at 0.8·106 cell/ml in 2L flasks. Transfection reagents 
were prepared by diluting 500 µg of the plasmids in Opti-MEM Reduced Serum Medium 
medium (Gibco), and after briefly mixing, 1500 µg PEI (Sigma-Aldrich) diluted in the same 
medium were added and further mixed. After 20 min incubation at room temperature, 
transfection mixtures were added to the cell cultures. Transfection was carried out for 48 h in 
previously described grown conditions. Pellets for the transfected cells were collected by 
centrifugation at 2000 rpm for 10 min, washed twice with chilled PBS buffer, frozen in liquid 
nitrogen and stored at -80ºC. For purification purposes, cells were resuspended in IP2 buffer 
(5 ml for 500 ml cell culture pellet) (10 mM Tris-HCl pH 8, 150 mM NaCl, 1 mM EGTA, 1% 
(v/v) NP-40) supplemented with Benzonase Nuclease (EMD-Millipore), proteases inhibitors 
(cOmplete™ EDTA-free, Roche) and phosphatases inhibitors (PhosSTOP™ EASYpack, 
Roche).  Cell lysis was performed by freezing/thawing in liquid nitrogen three times, and lysate 
was clarified by centrifugation at 35000 rpm for 1 h at 4ºC. 
 Supernatant was incubated with ANTI-FLAG M2 affinity resin (Sigma-Aldrich) previously 
equilibrated in IP2 buffer for 2 h at 4ºC with agitation. Using spin columns (SigmaPrep spin 
columns, Sigma-Aldrich), resin was subjected to washing steps with 5 resin volumes each: 
with IP2 buffer two times, IP 1M buffer (IP2 buffer with 1 M NaCl), F buffer (20 mM Tris-
HCl pH 7.5, 150 mM NaCl, 1.2 mM EGTA, 250 mM sucrose, 1% (v/v) Triton X-100, 0.5% 
(v/v) NP-40 two times, F250 buffer (F buffer supplemented with 250 mM LiCl), D buffer (20 
mM HEPES pH 8, 100 mM KCl, 0.2 mM EDTA, 5% (v/v) glycerol, 0.5% (v/v) NP-40, and 
D400 buffer (D buffer but with 400 mM KCl). Subsequently, the resin-bound protein was 
incubated with 5 mM ATP and 2 mM MgCl2 in TBS buffer (50 mM Tris-HCl pH 7.4, 150 mM 
NaCl) for 20 min at room temperature in order to remove contaminating HSP70 (as identified 
by liquid chromatography-mass spectroscopy), and further washed two times with buffer TBS. 
Elution was performed for 20 min at room temperature with TBS buffer supplemented with 
3xFLAG peptide (Sigma-Aldrich) at a final concentration of 0.15 µg/ml. 
 For the reconstitution of the RUVBL1-RUVBL2-DHX34 complex for structural studies, 
ANTI-FLAG M2 affinity resin loaded with 3xFLAG-DHX34 and after the washes, was 
incubated with a 6-fold molar excess of purified His-RUVBL1-RUVBL2 diluted in TBS 
buffer, further washed four times with TBS buffer, and eluted with 3xFLAG peptide as 
indicated for the 3xFLAG-DHX34 purification. In some preparations, endogenous HSP70 
chaperone was detected as a contaminant in the elution of the complex, but this could be 
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removed by incubating DHX34-loaded beads with ATP and Mg2+ and subsequent washes in a 
buffer without nucleotide, prior to binding RUVBL1-RUVBL2. 
 
In vitro pull-down experiments 
In vitro interaction assays were performed using pull-down experiments with purified proteins. 
For histidine affinity pull-down of His-RUVBL1-RUVBL2 and NMD factors, 7.5 µM of His-
RUVBL1-RUVBL2 (containing a 10 histidine tag at the N-terminus of RUVBL1 and wild-
type RUVBL2) were mixed with 2-fold molar excess of either UPF1115-914, UPF2, UPF3b, EJC, 
SMG1-SMG8-SMG9 or DHX34 in 30 µl reactions in binding buffer (20 mM HEPES pH 7, 
125 mM NaCl, 1 mM MgCl2, 10 mM imidazole, 2.5% (v/v) glycerol, 0.1% (v/v) NP-40). After 
15 min incubation at 4ºC, Ni-NTA agarose resin (Qiagen) previously equilibrated in binding 
buffer was added to the mixtures and further incubated for 30 min at 4ºC with agitation. 
Mixtures were included on centrifugation columns (SigmaPrep spin columns, Sigma-Aldrich), 
and unbound proteins were washed 4 times with 10 resin volumes of binding buffer 
supplemented with 50 mM imidazole, followed by elution with binding buffer supplemented 
with 500 mM imidazole. Inputs (2 µl) and elutions (10 µl) samples were analyzed by 4-15% 
SDS-PAGE (MINI-PROTEAN TGX stain-free, Bio-Rad) and staining with Quick Coomassie 
(Generon) or Oriole Fluorescent Gel Stain (Bio-Rad). Similar protocols were used in 
interactions assays between His-RUVBL1-RUVBL2 complex and 3xFLAG-DHX34_DCTD 
truncated mutant, and between either His-RUVBL1 (10 histidines tag at N-terminus) or 
RUVBL2-His (10 histidines tag at C-terminus) and 3xFLAG-DHX34. 
 For immunoaffinity pull-down experiments using FLAG or 3xFLAG tagged proteins, 
similar reaction mixtures were prepared for FLAG-SMG1-SMG8-SMG9 or 3xFLAG-DHX34 
and His-RUVBL1-RUVBL2 complex. ANTI-FLAG M2 affinity resin (Sigma-Aldrich) 
previously equilibrated in TBS buffer was added to the mixtures and incubated for 2 h at 4ºC 
with agitation. After that, resin was washed 4 times with 10 resin volumes of TBS buffer, and 
elution was performed by incubation for 30 min at room temperature with TBS buffer 
supplemented with either FLAG peptide (for FLAG-tagged proteins) or 3xFLAG peptide (for 
3xFLAG-tagged proteins) at a final concentration of 0.15 µg/ml. 
 
Cryo-EM 
3 µl of freshly purified RUVBL1-RUVBL2-DHX34 complex were applied to Quantifoil 300 
mesh R1.2/1.3 grids after glow discharge, and the sample was flash frozen in liquid ethane 
using FEI Vitrobot MAG IV (Thermo Fisher Scientific). 3047 movies were collected in a Titan 
Krios at eBIC (Diamond Light Source, Oxford, UK) using a GATAN K2 Summit detector in 
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counting mode, and a slit width of 20 eV on a GIF-Quantum energy filter. Cryo-EM images 
were collected as part of proposal EM20135 (Stop cancer - structural studies of 
macromolecular complexes involved in cancer by cryo-EM). Microscope calibrations and 
automatic data acquisition were performed with EPU software (Thermo Fisher Scientific) at a 
nominal magnification of ×47756, physical pixel size of 1.047 Å, a total dose of 48.1 e−/Å2, 6 
e−/Å2/s, 40 fractions, and three images per hole. Autofocus was performed using an objective 
defocus range between -1.5 and -3.0 µm. The oligomeric state of RUVBL1-RUVBL2 ATPase 
dead-mutants His-RUVBL1E303Q-RUVBL2E300Q was analyzed by EM of negative stained 
samples. 3 µl microliters of freshly purified complexes (0.01 mg/ml) were deposited onto 
freshly glow-discharged carbon-coated 400 mesh copper electron microscopy (EM) grids 
(Electron Microscopy Sciences) and stained using 2% (w/v) uranyl acetate. Grids were 
visualized on a Tecnai 12 transmission electron microscope (Thermo Fisher Scientific Inc.) 
with a lanthanum hexaboride cathode operated at 120 keV. Micrographs were recorded at 




MotionCor2 was used for local drift correction (5x5 patches) and dose-weighting of fraction 
stacks (Zheng et al., 2017). Parameters for the contrast transfer function (CTF) of drift-
corrected images were determined with Gctf (Zhang, 2016). A subset of manually picked 
particles was used to generate reference-free 2D averages in RELION (Zivanov et al., 2018) 
that were further used for template-based automatic particle picking using Gautomatch (K. 
Zhang, Yale University). Initial data set containing 353 057 particles was 2D-classified in 
RELION, and best quality particles were selected (121449). Ab initio 3D model was generated 
from the selected particles using cryoSPARC (Punjani et al., 2017), and used as reference for 
3D-classification in RELION-3 (Zivanov et al., 2018). After some 2D classification to select 
the most homogenous sub-class, image processing was divided in two branches (Figure 2 — 
figure supplement 1). To determine the structure of the full complex, we first classified the 
images using a mask to remove those particles with density too small to account for DHX34, 
obtaining a data sub-set of 41237 particles. These were classified in 3D and refined in RELION 
to generate a cryo-EM map with an estimated average resolution of 5.0 Å using gold-standard 
methods and the Fourier Shell Correlation (FSC) cut-off of 0.143. Due to the large difference 
in resolution within the map, showing high resolution in the AAA-ring and lower resolution in 
DHX34, the final volume was sharpened using LocalDeblur, an automatic local resolution-
based sharpening, as implemented in Scipion (Ramirez-Aportela et al., 2020). 
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 In a parallel branch, we removed the influence of DHX34 during image processing by using 
a mask in subsequent rounds of 3D classification and refinement. Refinement of the RUVBL1-
RUVBL2 was initiated from a preliminary refinement step (containing 101774 particles) and 
it was performed using a mask that excluded the density for DHX34 as well as the external 
OB-fold domains of RUVBL1-RUVBL2. An estimated average resolution of 4.2 Å was 
obtained for the RUVBL1-RUVBL2 using gold-standard FSC cut-off of 0.143. Local 
resolution distribution of the cryo-EM maps was estimated using ResMap (Swint-Kruse and 
Brown, 2005) as implemented in RELION-3. 
 To analyze the structure of DHX34 in the complex, the density was subtracted from the 
particles in the final map using a mask, as implemented in RELION-3 (Zivanov et al., 2018). 
Density subtracted particles were first subjected to a consensus refinement and further 3D 
classification. Significant heterogeneity was observed in 3D classified volumes, but these maps 
were not able to be refined due to the reduced number of particles. From the consensus 
refinement, a mask was applied to the volume for local refinement, obtaining a structure with 
an estimated average resolution of 10.4 Å using gold-standard FSC cut-off of 0.143. 
Negative staining EM micrographs obtained for His-RUVBL1E303Q-RUVBL2E300Q ATPase-
dead mutants were used for extracting 55776 particles after CTF parameters estimation and 
correction, and 2D reference-free averages for each complex were obtained using cisTEM 
(Grant et al., 2018). 
 
Atomic model building 
Atomic model building on the high resolution cryo-EM maps of the RUVBL1-RUVBL2 
ATPase ring was performed using the human RUVBL1-RUVBL2 crystal structure as starting 
model (PDB 2XSZ). After an initial rigid fitting in USCF Chimera, manual refinement for all 
the six chains was done using Coot (Emsley et al., 2010). The quality of the maps allowed the 
modeling of the majority of the side chains in the ATPase core of RUVBL1-RUVBL2 and the 
identification of the empty nucleotide pockets in all the three RUVBL2 present in the hexamer. 
Some regions of the DII domains were not as well defined in all the subunits, and we used the 
information of the three copies of each subunit in the ring to solve some of the ambiguities 
during modeling. A final step of automatic refinement was done in 
phenix.real_space_refinement to improve the geometries of the model (Afonine et al., 2018). 
 
ATPase assays 
  Lopez-Perrote et al. 2020  
 
 21 
ATP hydrolysis by His-RUVBL1-RUVBL2 was measured in a continuous spectrophotometric 
pyruvate kinase-lactate dehydrogenase-coupled assay, based on the regeneration of the 
hydrolyzed ATP coupled to oxidation of NADH (Nørby, 1988). NADH absorbance at 340 nm 
was measured using a Jasco V-550 UV/VIS Spectrophotometer with a Jasco EHC-477T 
Temperature Controller and monitored using the ND-1000 and Spectra Manager software in 
time course experiments, and its decrease was used to determine ATP hydrolysis rates. Assays 
were performed at 37ºC in 100 µl reactions in buffer 50 mM Tris-HCl pH 7.4, 150 mM NaCl, 
20 mM MgCl2, containing 2 mM phosphoenolpyruvate (PEP), 0.5 mM NADH, 0.04 U/µl 
pyruvate kinase/ 0.05 U/µl lactic dehydrogenase (Sigma-Aldrich) and 5 mM ATP. The reaction 
components without the protein of study where incubated for 10 min until stabilization of the 
absorbance at 340 nm to allow the system to regenerate contaminant ADP. ATP hydrolysis 
reactions were started by addition of 3 µM of His-RUVBL1-RUVBL2 (concentration 
calculated considering monomers), either wild-type or ATPase-dead mutants, and in the 
absence or presence of 1 µM DHX34D279A, and carried out for 20 min. We used the following 
ATPase-dead mutants: His-RUVBL1E303Q-RUVBL2, His-RUVBL1-RUVBL2E300Q and His-
RUVBL1E303Q-RUVBL2E300Q. A similar set of the experiments were performed with untagged 
RUVBL1-RUVBL2 complexes (wild-type and ATPase-dead mutants) after removal of the 
histidine tag present in RUVBL1. We also performed control experiments using wild-type 
DHX34 and the DHX34D279A mutant, and only buffer. Assays were performed at least by 
triplicate. ATP turnover (mol ATP/mol protein) indicated in min-1 was calculated for a time 
interval during which the absorbance decrease was linear. Values in the graph are indicated as 
percentage of the rate of the wild-type protein. 
 
Thermal Stability Determination 
Samples thermostability was measured by nano differential scanning fluorimetry using a Tycho 
NT.6 instrument (NanoTemper Technologies) that measures the intrinsic fluorescence from 
tryptophan and tyrosine residues detected at emission wavelengths of 350 and 330 nm, as 
a 30ºC · min−1 thermal ramp is applied from 35ºC to 95ºC. The observed changes in 
fluorescence signal allows to monitor the unfolding process of the protein. The temperature at 
which a transition occurs, the inflection temperature (Ti), was determined by detecting the 
maximum of the first derivative of the fluorescence ratios (F350/F330) after fitting 
experimental data with a polynomial function. 
 
Accession numbers 
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The cryo-EM maps of the RUVBL1-RUVBL2-DHX34 complex and the RUVBL1-RUVBL2 
ring have been deposited in the EM database with accession codes EMD-11788 and EMD-
11789 respectively. The structure of RUVBL1-RUVBL2 heterohexameric ring after binding 
of RNA helicase DHX34 has been deposited as PDB ID 7AHO. 
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Figure 1 | RUVBL1-RUVBL2 interacts with DHX34 
(A) Top panels: Schematic representation of RUVBL1 (blue) and RUVBL2 (pink) domains 
and catalytic motifs. Bottom panel: structure of the human RUVBL1-RUVBL2 hetero-
hexameric ring with protruding domain II (DII), generated from atomic structures of RUVBL1 
(PDB 2C9O) and RUVBL2 (PDB 6H7X) (Matias et al., 2006; Silva et al., 2018). Top and 
bottom views are shown with the color code from top panel. The ATPase-face and DII-face of 
the ring as well as the internal and external regions of DIIs are indicated. (B) Pull-down 
experiment testing the interaction of purified His-RUVBL1-RUVBL2 with DHX34, using His-
tag affinity purification. Proteins bound to affinity beads were eluted and analyzed by SDS-
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PAGE and stained using Oriole Fluorescent Gel Stain (Bio-Rad). DHX34 was found to elute 
specifically only when His-RUVBL1-RUVBL2 was present. (C, D) Immunoprecipitation (IP) 
of transiently transfected HEK293T cells with T7-DHX34 from HEK293T cells was performed 
in the presence of RNase A. Inputs (0.5%) and anti-FLAG-IPs (20%) were subjected to 
Western analysis using the indicated antibodies. Proteins bound to T7 tag affinity beads were 
eluted and analyzed by SDS-PAGE and Western blot using antibodies against the T7 tag in 
DHX34 and RUVBL1 (C) or RUVBL2 (D). For Inputs (0.5%) and anti-T7 IP (20%) are shown. 
(E) IP experiment testing the interaction of FLAG-RUVBL1 and HA-RUVBL2 co-expressed 
in HEK293T cells with T7-DHX34. Inputs (0.5%) and anti-FLAG-IPs (20%) were analyzed 
by SDS-PAGE and Western blot using antibodies against DHX34, RUVBL1 and RUVBL2. 
These antibodies detected both transfected and endogenous proteins and are indicated on the 
left site of the panel. 
Figure supplement for figure 1: 
Figure supplement 1 | Testing the interaction between RUVBL1-RUVBL2 and NMD factors 
 
  




Figure 2 | Cryo-EM of RUVBL1-RUVBL2 and the RUVBL1-RUVBL2-DHX34 complex 
(A) Purified RUVBL1-RUVBL2-DHX34 complex used for structural studies in a 4-15% SDS-
PAGE stained with Quick Coomassie (Generon). (B) Representative reference-free 2D 
averages from cryo-EM images of the complex. Side views clearly show the projection of one 
ring with some density attached to the DII face (close-up right panel). Scale bar represents 10 
nm. (C) Several views of the cryo-EM density obtained for RUVBL1-RUVBL2-DHX34 
(RUVBL1 in blue, RUVBL2 in pink, and DHX34 in grey). ATPase core and DII domains in 
RUVBL1-RUVBL2 are indicated. Scale bar represents 25 Å. 
Figure supplements for figure 2: 
Figure supplement 1| Image processing of the cryo-EM images of the RUVBL1-RUVBL2-
DHX34 complex 
Figure supplement 2 | Resolution estimation of the cryo-EM for the RUVBL1-RUVBL2-
DHX34 complex 
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Figure 3 | DHX34 induces large conformational changes in RUVBL2 
(A) Side and bottom views of the RUVBL1-RUVBL2 ring obtained after refinement without 
the influence of DHX34 and the OB-fold domains. Squares highlight N-terminal segments of 
RUVBL1 (blue) and RUVBL2 (pink). Scale bar represents 25 Å. The presence and absence of 
RUVBL1 and RUVBL2 N-terminal regions is indicated only in one copy of each subunit, but 
it applied to all the subunits in the complex. (B) Bottom view of the atomic structure of 
RUVBL1-RUVBL2 ring modeled from the cryo-EM density. Color codes are as in (A). (C) 
Right panel: a view of the nucleotide binding region in RUVBL2 from the crystal structure of 
RUVBL1-RUVBL2 (PDB 2SXZ) in grey color; left panel: similar view of RUVBL2 in 
RUVBL1-RUVBL2 after DHX34 binding (this work, pink). (D) Close-up view of the 
nucleotide-binding regions in RUVBL1, comparing the structure after DHX34 binding (left 
panel) and the crystal structure of the RUVBL1-RUVBL2 complex (PDB 2SXZ) (right panel) 
in grey. N-terminal histidines (H18 and H20) are indicated in grey, Walker A residues in 
orange, Walker B in red, and the Arg finger in yellow. (E) As in (D) but for the RUVBL2 
subunit. Color codes for relevant and catalytic motifs are represented as in (D). 
 
Figure supplement for figure 3: 
Figure supplement 1 | Resolution estimation of the cryo-EM for RUVBL1-RUVBL2 after 
DHX34 binding 
Figure supplement 2 | High-resolution features in cryo-EM map  
Figure supplement 3 | Analysis of conformational changes in each RUVBL2 subunit. 
Experiment 1 
Figure supplement 4 | Analysis of conformational changes in each RUVBL2 subunit. 
Experiment 2 
Figure supplement 5 | Analysis of conformational changes in each RUVBL2 subunit. 
Experiment 3 
  




Figure 4 | Mapping the interaction between DHX34 and RUVBL1-RUVBL2 in cells 
(A) Cartoon depicting the functional domains of DHX34, showing the residue numbers that 
define their boundaries. Names of the domains are: N-terminal (NTD), L, RecA1, RecA2, 
winged-helix (WH), Ratchet, OB-fold and C-terminal (CTD). (B-C) Effect of domain deletions 
of DHX34 (B) and larger truncation including several domains (C) on the interaction with 
RUVBL1 and RUVBL2 using cell extracts. The Immunoprecipitation (IP) of T7-tagged 
versions of DHX34 was analyzed by western blot using antibodies against the T7 tag, RUVBL1 
and RUVBL2. (D) Quantification of the experiments shown in “B” and “C”. The protein levels 
in the IP were quantified and normalized to the levels in the Input. Binding is expressed as IP 
enrichment compared to the empty vector control (-). For each expressed polypeptide at least 
two independent experiments were analyzed.   
Figure supplement for figure 4: 








Figure 5 | DHX34 down-regulates RUVBL2 ATPase activity 
 (A) Graph comparing the ATPase activity for His-RUVBL1-RUVBL2, His-RUVBL1E303Q-
RUVBL2, His-RUVBL1-RUVBL2E300Q and His-RUVBL1E303Q-RUVBL2E300Q shown as 
percentage of the rate measured for wild-type RUVBL1-RUVBL2. Standard deviations from 
three independent experiments are indicated. (B) Graph comparing the ATP activity of His-
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RUVBL1-RUVBL2 in the presence and absence of DHX34D279A, indicated as percentage of 
ATPase activity, assuming 100% activity for His-RUVBL1-RUVBL2. Standard deviations 
from four independent experiments are indicated. Sample His-RUVBL1-RUVBL2 used in 
these experiments contains a His-tag at the N-terminus of RUVBL1. (C) Graph showing the 
ATP activity for His-RUVBL1-RUVBL2 complexes where either RUVBL1 or RUVBL2 
contains a mutation that abolished ATP hydrolysis (RUVBL1303Q or RUVBL1E300Q) and the 
effect after incubation with DHX34D279A. In all the experiments the ATPase activity for His-
RUVBL1-RUVBL2 shown in “B” is considered as 100 %. Standard deviations from three 
independent experiments are indicated. (D) Model for the regulation of the ATPase activity of 
RUVBL1-RUVBL2 by DHX34. N-terminal regions in RUVBL1 (blue colour) and RUVBL2 
(pink colour) subunits contribute interactions with the nucleotides in the nucleotide-binding 
pocket. DHX34 binds to the DII-face of the RUVBL1-RUVBL2 ring and induces large 
conformational changes in the N-termini of all RUVBL2 subunits promoting the loss of 
nucleotide and a down-regulation of the ATPase activity. 
Source files containing the data used for the time course measurements for ATP consumption 
in figure 5 and the figure supplement are available in Figure 5—source data. 
Figure supplement for figure 5: 
Figure supplement 1 | Oligomerization and stability of RUVBL1-RUVBL2 and DHX34 
mutants. 
Figure supplement 2 | ATPase measurements and time courses for His-RUVBL1-RUVBL2 
and several ATPase-dead mutants in the presence and absence of DHX34D279A. 
Figure supplement 3 | DHX34D279A interferes with RUVBL1-RUVBL2 ATPase activity also 
after the His-tag in RUVBL1 was removed. 
 
  






Figure 1—figure supplement 1 | Testing the interaction between RUVBL1-RUVBL2 and 
NMD factors 
(A) Representative 2D averages of purified His-RUVBL1-RUVBL2 analyzed by cryo-EM. 
Scale bar, 10 nm. Features of the RUVBL1-RUVBL2 complex are indicated. (B) Pull-down 
experiment testing the interaction of purified His-RUVBL1-RUVBL2 with UPF1115-914, UPF2, 
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UPF3b and EJC using His-tag affinity purification. Proteins bound to affinity beads were eluted 
and analyzed by SDS-PAGE and stained using Quick Coomassie (Generon). None of these 
proteins interacted with RUVBL1-RUVBL2. Some elution detected for UPF2 (lane 14) 
corresponded to background binding by the beads since a similar elution was observed in the 
control experiment lacking His-RUVBL1-RUVBL2 (lane 10). (C) Immunoprecipitation assay 
testing the interaction of UPF1 and UPF2 with RUVBL1 and RUVBL2 using overexpressed 
FLAG-UPF1 and FLAG-UPF2 in cell extracts. Pulldowns show no increased signal for 
RUVBL1 and RUVBL2 compared to the negative control. (D) Immunoprecipitation 
experiment testing the interaction of endogenous UPF1 and UPF2 with RUVBL1 and 
RUVBL2 from cell extracts, using antibodies against endogenous UPF1 and UPF2. This 
experiment suggests that RUVBL1 and RUVBL2 do not interact with UPF1 or UPF2. Together 
with the lack of direct interaction detected in “C” and when using purified proteins in “B”, 
these experiments were interpreted as indicating a lack of interaction between RUVBL1-
RUVBL2 and either UPF1 or UPF2. (E) 4-15% SDS-PAGE showing a Ni-NTA agarose resin 
pull-down experiment of His-RUVBL1-RUVBL2 incubated with FLAG-SMG1-SMG8-
SMG9 (FLAG-SMG1-8-9), stained with Oriole Fluorescent Gel Stain (Bio-Rad). Lane 1 and 
3 correspond to the input and elution of an experiment containing only FLAG-SMG1-SMG8-
SMG9. Lane 2 and 4 correspond to the input and elution of an experiment containing FLAG-
SMG1-SMG8-SMG9 incubated with His-RUVBL1-RUVBL2. (F) SDS-PAGE of pull-down 
experiment as in (B) but using the FLAG tag in SMG1 as bait. Lane 1 and 3 correspond to the 
input and elution of an experiment containing FLAG-SMG1-SMG8-SMG9 and His-RUVBL1-
RUVBL2. Lane 2 and 4 corresponds to input and elution of an experiment containing only His-
RUVBL1-RUVBL2. (G) 4-15% SDS-PAGE and Quick Coomassie (Generon) staining of 
purified DHX34 constructs used: wild-type (wt) DHX34 and the DHX34 mutant lacking the 
CTD domain (DCTD) used in Figure 4—figure supplement 1D. 
 




Figure 2—figure supplement 1| Image processing of the cryo-EM images of the RUVBL1-
RUVBL2-DHX34 complex 
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Workflow of the image processing strategy followed in this work. After some initial steps of 
image “cleaning” and classification, a consensus refinement for 83.8 % of the particles was 
obtained. From these initial stages, image processing was divided in two branches. To resolve 
the structure of the RUVBL1-RUVBL2 without the effect of DHX34 and the OB-fold domains, 
we removed the influence of the density of these flexible regions by using a mask, and 
refinements and classifications were focused only in the ring. In parallel, we refined the 
structure of the full complex. For this, particles were first classified according to the quality of 
the DHX34 density, removing those particles were the density was too small to accommodate 
DHX34. Then, these particles were classified and refined using the information of the whole 
complex. Scale bar represents 25 Å. 
  





Figure 2—Figure supplement 2 | Resolution estimation of the cryo-EM for the RUVBL1-
RUVBL2-DHX34 complex. 
(A) Fourier Shell Correlation (FSC) curves estimating the average resolution of the cryo-EM 
volume of the RUVBL1-RUVBL2-DHX34 complex after refinement using the gold standard 
defined in RELION-3 (Zivanov et al., 2018). (B) Local resolution estimates map of RUVBL1-
RUVBL2-DHX34 complex as provided by RELION. Bottom and side views of the complex 
are shown using the color scale shown on the right. Scale bar, 25 Å. 




Figure 3—supplement 1 | Resolution estimation of the cryo-EM for RUVBL1-RUVBL2 
after DHX34 binding 
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(A) Fourier Shell Correlation (FSC) curves for the hexameric ring after refinement removing 
the influence of DHX34 and the OB-fold domains. (B) Local resolution estimates for the 
hexameric ring of RUVBL1-RUVBL2 as provided by RELION. Bottom and side views of the 
map are shown using the color scale shown on the right. Scale bar, 25 Å. (C) Close-up of the 
local resolution estimates centered in the nucleotide binding pockets of RUVBL1, showing all 
three subunits. Top panels show the density of the local resolution map using the same color 
code as in (B). Bottom panels show the same region but as a mesh with the atomic model fitted. 
(D) As “C”, but for each RUVBL2 subunit. 
  




Figure 3—Figure supplement 2 | High-resolution features in cryo-EM map  
 (A) Fourier Shell Correlation (FSC) curves for the atomic model versus the cryo-EM density 
of the RUVBL1-RUVBL2 ATPase core using for modeling. (B) Close-up views of RUVBL1 
(left) and RUVBL2 (right) internal DII domains superimposed with the structure of unliganded 
RUVBL1-RUVBL2 (PDB 2SXZ) in grey color. (C) Selected areas showing high-resolution 
features with side chain of some residues shown. Scale bar, 5 Å. 
  




Figure 3—supplement 3 | Analysis of conformational changes in each RUVBL2 subunit. 
Experiment 1. 
RUVBL1-RUVBL2-DHX34 particles were classified in 6 groups with a mask that removed 
the influence of DHX34 and the flexible DII domains from the analysis. Each sub-group was 
analyzed by fitting the atomic structure of the RUVBL1-RUVBL2 core domains (PDB 2XSZ). 
Cryo-EM density for RUVBL1-RUVBL2 is shown as a white transparency, RUVBL1 is shown 
in blue color and RUVBL2 in pink color. The percentage of particles in each subgroup is 
indicated. All groups showed density for the N-termini of RUVBL1. The N-termini of 
RUVBL2 present in the crystal structure is not present in the cryo-EM density of any subunit 
in any of the groups. The positions of the N-termini of RUVBL2 are indicated with asterisks. 




Figure 3—supplement 4 | Analysis of conformational changes in each RUVBL2 subunit. 
Experiment 2 
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RUVBL1-RUVBL2-DHX34 particles were classified in 6 groups with a mask centered in only 
one RUVBL1-RUVBL2 dimer at a time. Each sub-group was analyzed by fitting the atomic 
structure of the RUVBL1-RUVBL2 core domains (PDB 2XSZ). Cryo-EM density for 
RUVBL1-RUVBL2 is shown as a white transparency, RUVBL1 is shown in blue color and 
RUVBL2 in pink color. The percentage of particles in each subgroup is indicated. All groups 
showed density for the N-termini of RUVBL1. The N-termini of RUVBL2 present in the 
crystal structure is not present in the cryo-EM density of any subunit in any of the groups. The 
positions of the N-termini of RUVBL2 are indicated with asterisks. 
  





Figure 3—supplement 5 | Analysis of conformational changes in each RUVBL2 subunit. 
Experiment 3 
The conformation of each RUVBL1-RUVBL2 dimer was analyzed using a symmetry 
expansion strategy. Each particle was rotated twice along its longitudinal axis so that each of 
the 3 RUVBL1-RUVBL2 dimers in each particle locates in the same position. After the 
expansion the data set is triplicated. Then, particles were locally classified in 6 groups using a 
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mask focused in only one dimer. Each sub-group was analyzed by fitting the atomic structure 
of the RUVBL1-RUVBL2 core domains (PDB 2XSZ). Cryo-EM density for RUVBL1-
RUVBL2 is shown as a white transparency, RUVBL1 is shown in blue color and RUVBL2 in 
pink color. The percentage of particles in each subgroup is indicated. All groups showed 
density for the N-termini of RUVBL1. The N-termini of RUVBL2 present in the crystal 
structure is not present in the cryo-EM density of any subunit in any of the groups. The 
positions of the N-termini of RUVBL2 are indicated with asterisks. A small percentage of 
particles (2.1 %) showed a partial loss of density for RUVBL2 N-termini, which can be due in 
most part to the lower resolution of this subset. 
  




Figure 4—figure supplement 1 | Analysis of the images of DHX34 in complex with 
RUVBL1-RUVBL2. 
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(A) Workflow for the image processing of DHX34 extracted from the images of the RUVBL1-
RUVBL2-DHX34 complex. Scale bar, 25 Å. (B) Fourier Shell Correlation (FSC) curves for 
the DHX34 structure after refinement removing the influence of RUVBL1-RUVBL2 ring 
using density subtraction protocols.  (C) Comparison between the structure of isolated DHX34 
(Melero et al., 2014) and the DHX34 in complex with RUVBL1-RUVBL2 resolved at low 
resolution structure. Left panel, structure of isolated DHX34 as a solid density (Melero et al., 
2014). Right panel, structure of isolated DHX34 as mesh fitted with the low resolution DHX34 
from this work. Scale bar, 25 Å. (D) Effect of the truncation of the C-terminal domain (CTD) 
of DHX34 in the formation of a complex with RUVBL1-RUVBL2. The experiment was 
performed by pull-down of the His-tag in RUVBL1 in RUVBL1-RUVBL2 after incubation 
with DHX34-DCTD using purified proteins. SDS-PAGE was stained using Oriole Fluorescent 
Gel Stain (Bio-Rad). 
  




Figure 5—figure supplement 1 | Oligomerization and stability of RUVBL1-RUVBL2 and 
DHX34 mutants. 
(A) The oligomeric state of His-RUVBL1E303Q-RUVBL2E300Q mutant was monitored by using 
negative stain electron microscopy. His-RUVBL1E303Q-RUVBL2E300Q mutant assembled 
complexes similar to the wild-type complex when observed in the electron microscope (Figure 
1—figure supplement 1). (B) The stability of the His-RUVBL1-RUVBL2 mutants was 
analyzed using nano-scanning fluorimetry. Graph represents the first derivative of the 
fluorescence ratios (F350/F330) along the temperature for His-RUVBL1-RUVBL2 (solid 
line), and His-RUVBL1E303Q-RUVBL2E300Q (dot line). Inflection temperatures (Ti) are 
  Lopez-Perrote et al. 2020  
 
 52 
indicated on top.  (C) 4-15% SDS-PAGE and Quick Coomassie (Generon) staining of purified 
DHX34D279A. (D) Time course measurements for ATP consumption monitored as absorbance 
at 340 nm using the pyruvate kinase-lactate dehydrogenase-coupled assay to measure the 
ATPase activity of DHX34 and ATP-hydrolysis-dead mutant DHX34D279A. (E) Graph 
comparing the ATP activity in “D” indicated as a percentage of wild-type DHX34. ATP-
hydrolysis-dead mutant DHX34D279A mutant shows 24.2 % of the ATPase activity measured 
for wild-type DHX34. Standard deviations from three independent experiments are indicated.  
(F) The stability of DHX34 after incubation at 37ºC was analyzed by nano scanning 
fluorimetry. These experiments revealed that the protein was not affected after 20 min at 37ºC 
(dot line) but it was significantly affected after 40 min (dashed line), where a second unfolding 
process is observed at a higher Ti. 
Source files containing the data used for the time course measurements for ATP consumption 
in figure 5 and the figure supplement are available in Figure 5—source data. 
  




Figure 5—figure supplement 2 | ATPase measurements and time courses for His-RUVBL1-
RUVBL2 and several ATPase-dead mutants in the presence and absence of DHX34D279A. 
(A) Time course measurements for ATP consumption monitored as absorbance at 340 nm 
using the pyruvate kinase-lactate dehydrogenase-coupled assay for His-RUVBL1-RUVBL2 
(black line) and ATPase-dead mutants of His-RUVBL1E303Q-RUVBL2, His-RUVBL1-
RUVBL2E300Q and His-RUVBL1E303Q-RUVBL2E300Q. (B-D) Time course measurements were 
performed as in (A) in experiments measuring the ATPase activity of each mutant in the 
absence or presence of DHX34D279A. 
Source files containing the data used for the time course measurements for ATP consumption 
in figure 5 and the figure supplement are available in Figure 5—source data. 
 





Figure 5—figure supplement 3 | DHX34D279A interferes with RUVBL1-RUVBL2 ATPase 
activity also after the His-tag in RUVBL1 was removed. 
(A) Time course measurements for ATP activity monitored as absorbance at 340 nm for 
untagged RUVBL1-RUVBL2 (red line) compared to His-RUVBL1-RUVBL2 (black line). (B) 
Graph representing the ATPase activity for the experiments in (A) using the values of His-
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RUVBL1-RUVBL2 as the 100 %. (C, D) As in “A” and “B” respectively but after adding 
DHX34D279A. (E, F) As in “A” and “B” but using two ATPase-dead mutants RUVBL1-
RUVBL2E300Q and RUVBL1E303Q-RUVBL2. (G) Graph summarizing the ATPase activity of 
RUVBL1-RUVBL2 and several mutants in the absence or presence of DHX34D279A. This graph 
is similar to the one shown in Figure 4 but using untagged RUVBL1-RUVBL2 complex. 
Source files containing the data used for the time course measurements for ATP consumption 
in figure 5 and the figure supplement are available in Figure 5—source data. 
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Table 1 | Cryo-EM data collection and parameters 
 
  







(PDB ID 7AHO) 
Microscope FEI Titan Krios FEI Titan Krios 
Detector Gatan K2 (counting mode) Gatan K2 (counting 
mode) 
Magnification 47756 47756 
Voltage (kV) 300 300 
Electron exposure (e–/Å2) 48.1 (40 fractions) 48.1 (40 fractions) 
Defocus range (μm) -1.5 to -3.0 -1.5 to -3.0 
Pixel size (Å) 1.047 1.047 
Symmetry imposed C1 C1 
Initial particle images (no.) 353 057 353 057 
Final particle images (no.) 41237 101774 
Map resolution (Å) 





Map resolution range (Å)  4.0-12.0 3.8-6.0 
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Table 2 | Validation statistics for the atomic model of RUVBL1-RUVBL2 ATPase core 
 
Refinement RUVBL1-RUVBL2 ATPase core 
Software phenix.real_space_refine 
Coot 
Initial model used (PDB code) 2XSZ 
Model resolution (Å) 
  FSC threshold 
4.1 
0.5 
Map sharpening B factor (Å2) -222.98 
Model composition 
  Non-hydrogen atoms 
  Protein residues 






  Bond lengths (Å) 





  MolProbity score 
  Clashscore 





Ramachandran plot (%) 
  Favored 
  Allowed 
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Table 3 | Correlation Coefficients (CC) of the atomic after model refinement  
 
Correlation Coefficients (CC) after model refinement of RUVBL1-RUVBL2_core 
map 
CC (mask) 0.77 
CC (box) 0.72 
CC (peaks) 0.62 
CC (volume) 0.76 
Mean CC for ligands 0.84 
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Video 1. Cryo-EM structure of the RUVBL1-RUVBL2-DHX34 complex. Several views of 
the cryo-EM density of the RUVBL1-RUVBL2-DHX34 complex, colored as in Figure 2. 
 
Video 2: Atomic structure of the RUVBL1-RUVBL2 ATPase ring.  Several views of the 
atomic model for RUVBL1-RUVBL2 to show the conformational changes in the hexameric 
ring after the interaction with DHX34. During the video, the structure is superimposed to the 
atomic structure of the RUVBL1-RUVBL2 ATPase ring (PDB 2SXZ) in grey color, to 
highlight the differences in RUVBL2 and RUVBL1, and the loss of nucleotide in RUVBL2. 
In the final part of the video, the morphing between the crystal structure of the RUVBL1-
RUVBL2 ATPase ring (PDB 2SXZ) and the structure described is this work highlights the 
conformational changes induced by DHX34 in the polypeptide chains. During morphing, 
nucleotides in both subunits and both conformations have been removed, as well as the N-
terminal region of RUVBL2, which is only present in the crystal structure and it cannot be 
modeled in the DHX34-bound structure. 
 
Source Data File 
The file “Figure_5__source_data.xls” contains source data for the ATPase activity assays 
shown in Figure 5, Figure 5 – figure supplement 1, Figure 5 – figure supplement 2 and Figure 
5 – figure supplement 3. The file includes 15 sheets, each one for 1 sample, containing the 
replicas done for the sample. In each sheet it is included: 
• Name of sample  
• Time (min) 
• Absorbance at 340 nm for the replicas 
• Equation of the linear regression trendline for each replica used for data analysis 
• R2 value of the linear regression trendline for each replica 
 
Sheets related to Figure 5: 
Sheet 1: Figure5_source_1: Measurements for sample His-RUVBL1-RUVBL2 from Figure 5 
Panels A and B. 
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Sheet 2: Figure5_source_2: Measurements for sample His-RUVBL1-RUVBL2E300Q from 
Figure 5 Panels A and C. 
Sheet 3: Figure5_source_3: Measurements for sample His-RUVBL1E303Q-RUVBL2 from 
Figure 5 Panels A and C.  
Sheet 4: Figure5_source_4: Measurements for sample His-RUVBL1E303Q-RUVBL2E300Q from 
Figure 5 Panel A.  
Sheet 5: Figure5_source_5: Measurements for sample His-RUVBL1-RUVBL2 + DHX34D279A 
from Figure 5 Panel B.  
Sheet 6: Figure5_source_6: Measurements for sample His-RUVBL1-RUVBL2E300Q + 
DHX34D279A from Figure 5 Panel C.  
Sheet 7: Figure5_source_7: Measurements for sample His-RUVBL1E303Q-RUVBL2 + 
DHX34D279A from Figure 5 Panel C. 
      - Graphic in Figure 5 Panel A: plotting of the average of ATP hydrolysis indicated as 
percentage for His-RUVBL1-RUVBL2 (Figure5_source_1), His-RUVBL1-RUVBL2E300Q 
(Figure5_source_2), His-RUVBL1E303Q-RUVBL2 (Figure5_source_3) and His-
RUVBL1E303Q-RUVBL2E300Q (Figure5_ source_4). 
      - Graphic in Figure 5 Panel B: plotting of the average of ATP hydrolysis indicated as 
percentage for His-RUVBL1-RUVBL2 (Figure5_source_1) and His-RUVBL1-RUVBL2 + 
DHX34D279A (Figure5_source_5). 
      - Graphic in Figure 5 Panel C: plotting of the average of ATP hydrolysis indicated as 
percentage for His-RUVBL1-RUVBL2E300Q (Figure5_source_2), His-RUVBL1-
RUVBL2E300Q + DHX34D279A (Figure5_source_6), His-RUVBL1E303Q-RUVBL2 
(Figure5_source_3) and His-RUVBL1E303Q-RUVBL2 + DHX34D279A (Figure5_source_7). 
 
Sheets related to Figure 5 – figure supplement 1: 
Sheet 8: Figure5_source_8: Measurements for sample DHX34 from Figure 5 – figure 
supplement 1 Panels D and E.  
Sheet 9: Figure5_source_9: Measurements for sample DHX34D279A from Figure 5 – figure 
supplement 1 Panels D and E.  
      - Graphic in Figure 5 – figure supplement 1 Panel D: plotting of replica 1 from 
Figure5_source_8 (DHX34) and replica 2 from Figure5_source_9 (DHX34 D279A). 
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      - Graphic in Figure 5 – figure supplement 1 Panel D: plotting of the average of ATP 
consumption indicated as percentage for DHX34 (Figure5_source_8) and DHX34D279A 
(Figure5_source_9). 
 
Graphics in Figure 5 – figure supplement 2: 
      - Graphic in Figure 5 – figure supplement 2 Panel A: plotting of replica 4 from 
Figure5_source_1 (His-RUVBL1-RUVBL2), replica 3 from Figure5_source_2 (His-
RUVBL1-RUVBL2E300Q), replica 1 from Figure5_source_3 (His-RUVBL1E303Q-RUVBL2) 
and replica 1 from Figure5_source_4 (His-RUVBL1E303Q-RUVBL2 E300Q). 
      - Graphic in Figure 5 – figure supplement 2 Panel B: plotting of replica 4 from 
Figure5_source_1 (His-RUVBL1-RUVBL2) and replica 3 from Figure5_source_5 (His-
RUVBL1-RUVBL2 + DHX34D279A). 
      - Graphic in Figure 5 – figure supplement 2 Panel C: plotting of replica 3 from 
Figure5_source_2 (His-RUVBL1-RUVBL2E300Q) and replica 2 from Figure5_source_6 (His-
RUVBL1-RUVBL2E300Q + DHX34D279A). 
      - Graphic in Figure 5 – figure supplement 2 Panel D: plotting of replica 1 from 
Figure5_source_3 (His-RUVBL1E303Q-RUVBL2) and replica 1 from Figure5_source_7 (His-
RUVBL1E303Q-RUVBL2 + DHX34D279A). 
 
Sheets related to Figure 5 – figure supplement 3: 
Sheet 10: Figure5_S3_source_10: Measurements for sample Untagged RUVBL1-RUVBL2 
from Figure 5 – figure supplement 3 Panels A, B, C and D. 
Sheet 11: Figure5_S3_source_11: Measurements for sample Untagged RUVBL1-RUVBL2 + 
DHX34D279A from Figure 5 – figure supplement 3 Panels B and D. 
Sheet 12: Figure5_S3_source_12: Measurements for sample Untagged RUVBL1-
RUVBL2E300Q from Figure 5 – figure supplement 3 Panels E and G. 
Sheet 13: Figure5_S3_source_13: Measurements for sample Untagged RUVBL1-
RUVBL2E300Q + DHX34D279A from Figure 5 – figure supplement 3 Panels E and G. 
Sheet 14: Figure5_S3_source_14: Measurements for sample Untagged RUVBL1E303Q-
RUVBL2 from Figure 5 – figure supplement 3 Panels F and G. 
Sheet 15: Figure5_S3_source_15: Measurements for sample Untagged RUVBL1E303Q-
RUVBL2 + DHX34D279A from Figure 5 – figure supplement 3 Panels F and G. 
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      - Graphic in Figure 5 – figure supplement 3 Panel A: plotting of replica 4 from 
Figure5_source_1 (His-RUVBL1-RUVBL2) and replica 1 from Figure5_S3_source_10 
(Untagged RUVBL1-RUVBL2). 
      - Graphic in Figure 5 – figure supplement 3 Panel A: plotting of the average of ATP 
consumption indicated as percentage for His-RUVBL1-RUVBL2 (Figure5_source_1) and 
Untagged RUVBL1-RUVBL2 (Figure5_S3_source_10). 
      - Graphic in Figure 5 – figure supplement 3 Panel C: plotting of replica 1 from 
Figure5_S3_source_10 (Untagged RUVBL1-RUVBL2) and replica 1 from 
Figure5_S3_source_11 (Untagged RUVBL1-RUVBL2 + DHX34D279A). 
      - Graphic in Figure 5 – figure supplement 3 Panel D: plotting of the average of ATP 
consumption indicated as percentage for Untagged RUVBL1-RUVBL2 
(Figure5_S3_source_10) and Untagged RUVBL1-RUVBL2 + DHX34D279A 
(Figure5_S3_source_11). 
      - Graphic in Figure 5 – figure supplement 3 Panel E: plotting of replica 1 from 
Figure5_S3_source_12 (Untagged RUVBL1-RUVBL2E300Q) and replica 2 from 
Figure5_S3_source_13 (Untagged RUVBL1-RUVBL2E300Q + DHX34D279A). 
      - Graphic in Figure 5 – figure supplement 3 Panel F: plotting of replica 3 from 
Figure5_S3_source_14 (Untagged RUVBL1E303Q-RUVBL2) and replica 1 from 
Figure5_S3_source_15 (Untagged RUVBL1E303Q-RUVBL2 + DHX34D279A). 
      - Graphic in Figure 5 – figure supplement 3 Panel G: plotting of the average of ATP 
consumption indicated as percentage for Untagged RUVBL1-RUVBL2E300Q 
(Figure5_S3_source_12), Untagged RUVBL1-RUVBL2E300Q + DHX34D279A 
(Figure5_S3_source_13), Untagged RUVBL1E303Q-RUVBL2 (Figure5_S3_source_14) and 
Untagged RUVBL1E303Q-RUVBL2 + DHX34D279A (Figure5_S3_source_15). 
 
 
